ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,0804
-0,12%
Bitcoin
69.362,15
0,04%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Loxo Oncology, Inc. (LOXO)

  7. Loxo Oncology, Inc. (LOXO) News

LOXO

LOXO ONCOLOGY, INC. (LOXO)

Loxo Oncology, Inc.
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LOXO
DatumZeitQuelleÜberschriftSymbolFirma
14/02/202018h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LOXOLoxo Oncology, Inc.
08/01/202021h11Edgar (US Regulatory)Schedule 13gNASDAQ:LOXOLoxo Oncology, Inc.
25/02/201917h29Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:LOXOLoxo Oncology, Inc.
22/02/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h56Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h52Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h48Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h46Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h41Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h39Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201922h07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h23PR Newswire (US)Lilly Completes Acquisition of Loxo OncologyNASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h22Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
15/02/201915h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOXOLoxo Oncology, Inc.
 Showing the most relevant articles for your search:NASDAQ:LOXO

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
SOLUSD
Solana
NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
TG
TUI1
Tui
TG
BAYN
Bayer
DBI
TDXP
Tec DAX
TG
ALV
Allianz
FX
EURJPY
Euro vs Yen
NYSE
MCD
McDonalds
CCOM
US100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten